Gordan Srkalović

Sparrow Health System — United States

Medicine · Health Sciences

37h-index9.7kcitations139works4.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral-associated cancers and disorders(22), Multiple Myeloma Research and Treatments(21), Lymphoma Diagnosis and Treatment(19), Cancer Genomics and Diagnostics(15), Cancer Treatment and Pharmacology(15)

Publications137 total

Breast-implant associated unicentric castleman disease: a case report
Current Problems in Cancer Case Reports·2026Open Access
Pediatric idiopathic multicentric castleman disease is often severe and responds to siltuximab
Blood·2025
PL03.06 EA5181: Phase 3 Trial of Concurrent and Consolidative Durvalumab vs Consolidation Durva Alone for Unresectable Stage 3 NSCLC
Journal of Thoracic Oncology·2025· 3 cited
Abstract RF1-04: Long-Term Follow-up and updated analysis from S0221, Comparing Alternative Dose-Schedules of Adjuvant Anthracycline/Taxane Therapy in High-Risk Early Breast Cancer
Clinical Cancer Research·2025
Variable response rates across chemotherapy regimens for severe idiopathic multicentric Castleman disease.
Journal of Clinical Oncology·2025· 1 cited
The immunotherapy breakthroughs in cervical cancer: Focus on potential biomarkers and further therapy advances
Biomolecules and Biomedicine·2025· 1 citedOpen Access
Abstract CT226: Sunitinib (S) in patients (pts) with solid tumors with <i>FGFR2</i> alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Cancer Research·2025
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry
Blood Advances·2025· 13 citedOpen Access
A Short Course of Standard Velcade/Dexamethasone Followed by Unlimited Weekly Maintenance Therapy Is an Effective Treatment in Relapsed/Refractory Multiple Myeloma
Cancers·2024Open Access
The Development of Diagnostic Criteria and Utilization of Excisional Lymph Node Biopsies Shorten Time to Diagnosis for Idiopathic Multicentric Castleman Disease
Blood·2024· 2 citedOpen Access
1309P A genomic scar based signature (HRDsig) and biallelic BRCA alterations identify a homologous recombination deficiency (HRD) phenotype of non-small cell lung cancer (NSCLC) potentially actionable to the PARP inhibitor rucaparib: Post-hoc analysis of lung-MAP substudy S1900A
Annals of Oncology·2024· 2 citedOpen Access
Analysis of blood immune biomarkers and fecal microbiome in subjects with and without malignant solid tumors: report from a feasibility study
Gastroenterology and Functional Medicine·2024Open Access
Increase in Vascular Endothelial Growth Factor (VEGF) Expression and the Pathogenesis of iMCD-TAFRO
Biomedicines·2024· 8 citedOpen Access
Talazoparib in Patients With Solid Tumors With <i>BRCA1</i>/<i>2</i> Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study
JCO Precision Oncology·2024· 1 cited
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease
Haematologica·2024· 11 citedOpen Access
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes
Blood Advances·2023· 22 citedOpen Access
Ongoing symptoms following complete surgical excision in unicentric Castleman disease
American Journal of Hematology·2023· 5 citedOpen Access
Temsirolimus (T) in patients (pts) with solid tumors with <i>PIK3CA </i>mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
Journal of Clinical Oncology·2023· 1 cited
Talazoparib (Tala) in patients (pts) with solid tumors with <i>BRCA1/2 </i>mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
Journal of Clinical Oncology·2023· 1 cited
Increased Comorbidities and Hospitalizations Associated with Idiopathic Multicentric Castleman Disease
Blood·2022· 2 cited
page 1 of 7Next →

Frequent Co-authors

Andrew V. Schally(15), Tommie W. Redding(8), David C. Fajgenbaum(7), Mohamad A. Hussein(7), L. Bokser(7), Bart Barlogie(6), Frits van Rhee(6), Megan S. Lim(6), Paul G. Richardson(5), James R. Berenson(5), Seema Singhal(5), Sundar Jagannath(5), Kenneth C. Anderson(5), Mary Jo Lechowicz(5), Sheila K. Pierson(5), Amy Chadburn(5), Corey Casper(5), Alexander Fosså(5), Éric Oksenhendler(5), Tamás Janáky(5)